LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance. [PDF]
Hovey OFJ +11 more
europepmc +1 more source
Assessment of Tfh Cells and Related Molecules in CML-CP Patients With Different Molecular Responses. [PDF]
Wang Y +12 more
europepmc +1 more source
Streptomyces koyangensis L-asparaginase: computational prediction of dual-mechanism BCL-2 interaction in acute lymphoblastic leukemia. [PDF]
Solanki G +5 more
europepmc +1 more source
Chronic Myeloid Leukemia: Historical Perspective, Pathophysiology, and Treatment Advances.
Tungjitviboonkun S, Daran L, Unsuwan S.
europepmc +1 more source
Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell Lines. [PDF]
Okabe S +4 more
europepmc +1 more source
Inhibition of Pellino-1 reverts the progression and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [PDF]
Zhou Q +11 more
europepmc +1 more source
Related searches:
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation
Leukemia Research, 2008We have developed a simplified sandwich immunoassay to measure free circulating total and phosphorylated fusion BCR-ABL protein in patients with the t(9;22)(q34;q11) chromosomal translocation. The assay is based on immunoprecipitating BCR-ABL protein using beads coated with anti-BCR antibody and detecting the fusion protein with anti-ABL antibody and ...
Kapil Bhalla +2 more
exaly +3 more sources
Nuclear topography, expression of the BCR/ABL fusion gene and its protein level/cellular pattern were studied in CML cell line K562 stimulated to differentiation, apoptosis and influenced by ABL-RNA interference (ABL-RNAi). Phorbol ester-induced maturation of K562 cells was accompanied by repositioning of down-regulated BCR/ABL genes closer to the ...
Eva Bártová +2 more
exaly +3 more sources
Characterization of a Monoclonal Antibody Specific for Novel Bcr/Abl Out-of-Frame Fusion Proteins
The new tumor-specific antigens Bcr/Abl-OOF, identified in Philadelphia chromosome (Ph)-positive leukemia cells, are derived from an alternative splicing event involving BCR exons 1, 13, or 14 and ABL exons 4 and 5. The COOH-terminus of these transcription products contain an amino acid portion derived from an out-of-frame (OOF) reading of the ABL gene;
Casnici C +8 more
openaire +5 more sources

